Molecular Biomarkers & Diagnosis

Yong Xu

Publications

• Review Article
  The Efficacy and Safety of Acarbose compared with Voglibose in Patients with Type 2 Diabetes: A Systematic Review and Meta-Analysis
  Author(s): Lian Liu, Song Wei Su, Yong Xu, Qin Wan, Xiao Ling Yang, Yu Ying Tang and Hong Yan SunLian Liu, Song Wei Su, Yong Xu, Qin Wan, Xiao Ling Yang, Yu Ying Tang and Hong Yan Sun
  
  Background: Acarbose and voglibose are alpha-glucosidase inhibitors and they are an effective therapy in patients with diabetes mellitus. Our aim is to directly compare the efficacy and safety of acarbose and voglibose for the treatment of patients with type 2 diabetes. Methods: We searched the international web databases (PubMed, EMBASE, Cochrane Library, Web of Science) with an English language restriction (up to August, 2016). In addition, we checked bibliographies of each included study and the latest reviews to identify additional studies. For each clinical outcome, dichotomous data were analyzed by using the risk ratio (RR) with the 95% confidence interval (CI). Continuous outcomes measured on the same scale and units were analyzed by using weighted mean differences (WMD) with the 95% confidence interval (CI); if continuous outcomes were m.. Read More»
  DOI: 10.4172/2155-9929.1000375

  Abstract PDF